Literature DB >> 760751

Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.

G J Davies, P K Marrott, J R Muir.   

Abstract

1 The haemodynamic and electrocardiographic effects of intravenous disopyramide were studied in fifteen patients with acute myocardial infarction. 2 Five minutes after drug injection a rise in heart rate, aortic mean and diastolic pressures and systemic vascular resistence was noted which persisted for at least 30 min. A small increase in pulmonary arterial diastolic pressure (mean = 1.5 mm Hg) occurred at 5 min only and no significant change of cardiac output was found throughout the period of the study (1 h). 3 Surface electrocardiograms revealed transient prolongation of the P-R interval and a sustained increase in the QTc interval. 4 The haemodynamic changes suggest an anticholinergic effect of the drug. There was no definite evidence of a negative inotropic effect in this study, however, these peripheral haemodynamic measurements might not have revealed a modest negative inotropic effect. 5 The electrocardiographic changes are similar to those previously reported in normals and in patients without acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760751      PMCID: PMC1429441          DOI: 10.1111/j.1365-2125.1979.tb00919.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Changes in cardiac output, stroke volume, and central venous pressure induced by atropine in man.

Authors:  J N BERRY; H K THOMPSON; D E MILLER; H D McINTOSH
Journal:  Am Heart J       Date:  1959-08       Impact factor: 4.749

2.  Disopyramide: a study of its acute electrophysiological and haemodynamic effects [proceedings].

Authors:  P K Marrott; M S Ruttley; J T Winterbott; J R Muir
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

3.  Pharmacology of a new antiarrhythmic agent, gamma-diisopropyl-amino-alpha-phenyl-alpha-(2-pyridyl)-butyramide (SC-7031).

Authors:  C M MOKLER; C G VAN ARMAN
Journal:  J Pharmacol Exp Ther       Date:  1962-04       Impact factor: 4.030

4.  Relationship of the pulmonary artery end-diastolic pressure to the left ventricular end-diastolic and mean filling pressures in patients with and without left ventricular dysfunction.

Authors:  R E Falicov; L Resnekov
Journal:  Circulation       Date:  1970-07       Impact factor: 29.690

5.  [Prevention of arrhythmias in myocardial infarct with disopyramide].

Authors:  A Selvini
Journal:  Minerva Med       Date:  1970-09-05       Impact factor: 4.806

6.  Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.

Authors:  P P Mathur
Journal:  Am Heart J       Date:  1972-12       Impact factor: 4.749

  6 in total
  5 in total

1.  The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.

Authors:  K M Giacomini; S E Swezey; K Turner-Tamiyasu; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

2.  [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].

Authors:  C Angermann; G Autenrieth
Journal:  Klin Wochenschr       Date:  1981-07-15

Review 3.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

4.  Disopyramide and lignocaine. A comparison of cardiac effects using echocardiography.

Authors:  M A Martin; N D Bax; G T Tucker; J W Ward
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

5.  Negative inotropic effects of disopyramide on guinea-pig papillary muscles.

Authors:  N Kondo; M Mizukami; S Shibata
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.